日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate/hnRNPA1 lactylation/AR-V7 axis.

KDM5B 驱动的葡萄糖代谢重编程通过乳酸/hnRNPA1 乳酸化/AR-V7 轴促进前列腺癌对恩扎卢胺的耐药性。

Sun Rui, Huang Yong, He Hao, Li Qiuchen, Wang Linfeng, Zhang Gaojie, Wei Ziling, Cao Yang, Li Jing, Wang Xianmin, Yang Fan, Chen Wenjun, Li Xiang, Yu Jiang, Liu Siyuan, Lei Congfeng, Jiang Yu, Peng Yueqiang, Su Huiyi, Gao Yingying, He Weiyang, Yang Lei, Liu Jiayu

Transition of Néel-Type and Bloch-Néel Hybrid Skyrmion in a Metallic Multilayer Material System

金属多层材料体系中尼尔型和布洛赫-尼尔混合型斯格明子的转变

Wang, Binbin; Bagués, Núria; Cheng, Shuyu; Das, Shekhar; Selcu, Camelia; Li, Ziling; Freyermuth, Jacob B; Pelekhov, Denis V; Hammel, P Chris; Randeria, Mohit; Kawakami, Roland K; McComb, David W

A triple combination strategy for nasopharyngeal carcinoma: Aptamer-guided liposomal chemotherapy, engineered NK cells, and Fc-enhanced PD-L1 antibody therapy

鼻咽癌的三联疗法:适体指导的脂质体化疗、基因工程改造的NK细胞和Fc增强的PD-L1抗体疗法

Yao, Chaoyan; Wang, Lei; Liu, Weidong; Shi, Ning; Liao, Ziling; Fu, Yuxuan; Ouyang, Jinhao; Lei, Xuan; Huang, Qianping; Li, Siyu; Zhouyang, Yihua; Zhao, Pinnan; Wang, Jie; Xu, Hongjuan; Zhou, Wenhu; Jiang, Xingjun; Gao, Xiang; Ren, Caiping; Luo, Longlong

Applications of AI/ML in accelerating the development of pulmonary drug delivery system

人工智能/机器学习在加速肺部药物输送系统开发中的应用

Jiang, Junhuang; Zhou, Ziling; Peng, Tingting; Huang, Zhengwei; Pan, Xin; Wu, Chuanbin

Fe-Based Nanocrystalline Magnetic Shielding Cylinder with Subfemtotesla-Level Magnetic Noise

具有亚飞特斯拉级磁噪声的铁基纳米晶磁屏蔽圆柱体

Shen, Peipei; Ma, Danyue; Wang, Kun; Li, Shuang; Gao, Yanan; Wang, Pengfei; Yuan, FuSen; Chen, Hua; Wang, Zhuo; Liu, Ziling; Xie, Meng; Li, Bo; Zhou, Hongbo; Sun, Baoan

Regulating Tumor Metabolic Reprogramming with Biomimetic Co-Delivery of Simvastatin and Kynureninase for Immunotherapy

利用仿生方式共递送辛伐他汀和犬尿氨酸酶来调控肿瘤代谢重编程,以用于免疫治疗

Yin, Jiaxin; Yang, Shengcai; Liu, Zengguang; Zhao, Songchen; Sun, Siyu; Liu, Ziling; Li, Quanshun

EM2, a Natural Product MST1/2 Kinase Activator, Suppresses Non-Small Cell Lung Cancer via Hippo Pathway Activation.

EM2 是一种天然产物 MST1/2 激酶激活剂,可通过激活 Hippo 通路抑制非小细胞肺癌。

Yang Siyu, Xie Huayan, Lin Qiang, Zhou Liujin, Liu Junxi, Fang Zekai, Tang Ziling, Yuan Ruijie, Su Jinxuan, Li Sijia, Wang Wenlin, Pan Mingyu, Wang Hao, Dai Xiaoyong, Wang Guocai, Zhang Yubo

Oncolytic Therapy: Delivery System and New Therapeutic Strategies for Cancer

溶瘤疗法:癌症的递送系统和新型治疗策略

Jin, Sikan; Zhang, Yi; Zhou, Ziling; Zhang, Yaqi; Yu, Ting; Xu, Rui; Xu, Lin; Zhang, Jidong; Zhang, Longze; Yang, Shan; Wang, Xianyao

Macrophage NEDD4L restrains liver fibrosis by preventing scar-associated macrophage expansion via ubiquitination of phospho-SMAD3.

巨噬细胞 NEDD4L 通过泛素化磷酸化 SMAD3 来抑制瘢痕相关巨噬细胞的扩张,从而抑制肝纤维化。

He Yanghuan, Ge Shujun, Ling Shijia, Yang Siting, Yang Feiran, Liu Xinyi, Dong Siyue, Chen Yingfen, Zhang Ziling, Zhou Yue, Hwang Seonghwan, Kim Seung-Jin, Wang Peng, He Yong, Chen Yuanwen

Noninvasive prediction of occult pT3a upstaging in localized ccRCC with radiogenomic insights and prognostic relevance

利用放射基因组学见解和预后相关性,对局限性透明细胞肾细胞癌中隐匿性pT3a分期升级进行无创预测

Li, Shichao; Wang, Chuhuai; Li, Feng; Gao, Mengmeng; He, Kangwen; Zhou, Ziling; Qu, Weinuo; Shen, Yaqi; Chu, Qian; Wu, Shan; Qu, Jinrong; Zhang, Yudong; Li, Zhen